Biocatalytic pathways are engineered to control the stereoselective formation of sulfur-carbon bonds. This enables the high-purity production of L-glufosinate and related derivatives over racemic chemical methods.
The keywords indicate a focus on variants and specific microorganisms to overcome the metabolic bottleneck of converting O-acylhomoserine into sulfur-containing amino acids. Improving this conversion efficiency is critical for industrial-scale methionine yields.